Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy.

Dorward J., Sookrajh Y., Lessells R., Bulo E., Bodley N., Singh L., Moodley P., Samsunder N., Drain PK., Hayward G., Butler CC., Garrett N.

DOI

10.1097/QAI.0000000000003385

Type

Journal article

Journal

J Acquir Immune Defic Syndr

Publication Date

15/04/2024

Volume

95

Pages

e8 - e11

Permalink Original publication